This is not the most recent version of this material.
For an updated version, please see the relevant topic page.
Orphan Drug Assessment: Final Framework Adaptations
There is a new version of this document, updated in 2020, available here.
ICER’s 2017 modifications to its value assessment framework for reviews of certain treatments for serious, ultra-rare diseases.
View All Materials on this Topic or Go Back to View More Materials